Progress in the development of a recombinant vaccine for human hookworm disease: The Human Hookworm Vaccine Initiative
- 1 August 2003
- journal article
- review article
- Published by Elsevier in International Journal for Parasitology
- Vol. 33 (11) , 1245-1258
- https://doi.org/10.1016/s0020-7519(03)00158-9
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- China's HookwormsThe China Quarterly, 2002
- EFFECT OF VACCINATIONS WITH RECOMBINANT FUSION PROTEINS ON ANCYLOSTOMA CANINUM HABITAT SELECTION IN THE CANINE INTESTINEJournal of Parasitology, 2002
- Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificityThe FASEB Journal, 2002
- Epidemiology of Necator Americanus Hookworm Infections in Xiulongkan Village, Hainan Province, China: High Prevalence and Intensity Among Middle-Aged and Elderly ResidentsJournal of Parasitology, 2001
- Helminths, Human Immunodeficiency Virus and TuberculosisScandinavian Journal of Infectious Diseases, 2001
- The epidemiology of human hookworm infections in the southern region of MaliTropical Medicine & International Health, 2000
- Protection in lambs vaccinated with Haemonchus contortus antigens is age related, and correlates with IgE rather than IgG1 antibodyParasite Immunology, 2000
- Antibody‐Dependent Reductions in Mouse Hookworm Burden after Vaccination withAncylostoma caninumSecreted Protein 1The Journal of Infectious Diseases, 1999
- Vaccination with Alum-Precipitated Recombinant Ancylostoma-Secreted Protein 1 Protects Mice against Challenge Infections with Infective Hookworm (Ancylostoma caninum) LarvaeThe Journal of Infectious Diseases, 1996
- Acasp,a Gene Encoding a Cathepsin D-like Aspartic Protease from the HookwormAncylostoma caninumBiochemical and Biophysical Research Communications, 1996